Dentsply Sirona (XRAY) EBITDA (2009 - 2026)

Dentsply Sirona's EBITDA history runs 18 years deep, the most recent figure standing at -$35.0 million for Q1 2026.

• Quarterly EBITDA fell 155.56% year-over-year to -$35.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$520.0 million (up 39.39% YoY) and the FY2025 annual result came in at -$422.0 million, up 51.99% from the prior year.
• EBITDA was -$35.0 million for Q1 2026 at Dentsply Sirona, up from -$139.0 million in the prior quarter.
• Across five years, EBITDA topped out at $119.0 million in Q2 2022 and bottomed at -$1.2 billion in Q3 2022.
• A 5-year average of -$138.7 million and a median of -$2.0 million in 2023 frame the typical range for EBITDA.
• Annual changes were most pronounced in 2022 — EBITDA sank 1022.73% — and 2024, when it jumped 2200.0%.
• Dentsply Sirona's EBITDA stood at $65.0 million in 2022, then gained by 12.31% to $73.0 million in 2023, then tumbled by 797.26% to -$509.0 million in 2024, then jumped by 72.69% to -$139.0 million in 2025, then soared by 74.82% to -$35.0 million in 2026.
• Business Quant data shows XRAY's EBITDA at -$35.0 million in Q1 2026, -$139.0 million in Q4 2025, and -$218.0 million in Q3 2025.